[EN] PHOSPHODIESTERASE INHIBITORS<br/>[FR] INHIBITEURS DE PHOSPHODIESTÉRASE
申请人:US GOV HEALTH & HUMAN SERV
公开号:WO2009089027A1
公开(公告)日:2009-07-16
The invention relates to compounds of formula I useful for inhibiting phosphodiesterase-4.
这项发明涉及到公式I的化合物,用于抑制磷酸二酯酶-4。
TRIAZOLOPYRIDAZINE COMPOUNDS, USE AS INHIBITORS OF THE KINASE LRRK2, AND METHODS FOR PREPARATION THEREOF
申请人:SOUTHERN RESEARCH INSTITUTE
公开号:US20130296298A1
公开(公告)日:2013-11-07
The present invention provides novel LRRK2 kinase inhibitors and methods of treating disease states using these inhibitors.
本发明提供了新型LRRK2激酶抑制剂,并使用这些抑制剂治疗疾病状态的方法。
PHOSPHODIESTERASE INHIBITORS
申请人:Thomas Craig J.
公开号:US20110112079A1
公开(公告)日:2011-05-12
The invention related to compounds for formula I useful for inhibiting phosphodiesterase-4.
该发明涉及公式I的化合物,用于抑制磷酸二酯酶4。
Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase
作者:Ron Grey、Albert C. Pierce、Guy W. Bemis、Marc D. Jacobs、Cameron Stuver Moody、Rahul Jajoo、Narinder Mohal、Jeremy Green
DOI:10.1016/j.bmcl.2009.04.061
日期:2009.6
A series of substituted 3-aryl-6-amino-triazolo[4,3-b]pyridazines were identified as highly selective inhibitors of Pim-1 kinase. Initial exploration identified compound 24 as a potent, selective inhibitor, limited in its utility by poor solubility and permeability. Understanding the unusual ATP-binding site of the Pim kinases and X-ray crystallographic data on compound 24 led to design improvements in this class of inhibitor. This resulted in compound 29, a selective, soluble and permeable inhibitor of Pim-1. (C) 2009 Elsevier Ltd. All rights reserved.